Forbion et al. sell Santaris Pharma to Roche for $450m
An investor consortium comprising Sunstone Capital, Gilde Healthcare and Forbion Capital among others has sold Danish biopharma business Santaris to Swiss healthcare firm Roche for $450m.
More on Exits
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt
Inflexion kicks off Rosemont Pharmaceuticals sale
Liquid pharmaceuticals manufacturer has drawn strategic and PE interest ahead of non-binding offers
Peach owner Inflexion to revisit exit plans via Arma Partners
GP bought the video advertising company from Vitruvian in 2016 and had explored a sale last year
Livingbridge appoints Raymond James to sell FluidOne
UK-based cloud solutions firm has made several add-ons since its acquisitoin from Rigby Group in 2019
Latest News
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
Permira to acquire majority stake in Gruppo Florence
Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs
Stockholm-based investor is considering divestments, although challenging market remains a barrier
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt